![]() |
Volumn 37, Issue 7, 2005, Pages 3187-3189
|
Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and lamivudine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
CORTICOSTEROID;
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIBODY;
LAMIVUDINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
AGED;
ARTERY THROMBOSIS;
ARTICLE;
BILE DUCT OBSTRUCTION;
CHOLANGITIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRITICAL ILLNESS;
DEATH;
DISEASE COURSE;
DONOR;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
EXPOSURE;
FEMALE;
FOLLOW UP;
GRAFT FAILURE;
HEART FAILURE;
HEPATIC ARTERY;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
LIVER CELL CARCINOMA;
LIVER FAILURE;
LIVER GRAFT;
LIVER GRAFT REJECTION;
LONG TERM CARE;
MALE;
MEDICAL ASSESSMENT;
METASTASIS;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECIPIENT;
RECURRENT CANCER;
RECURRENT INFECTION;
REOPERATION;
SEPSIS;
SURVIVAL TIME;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
FEMALE;
GRAFT SURVIVAL;
HEPACIVIRUS;
HEPATITIS B ANTIBODIES;
HEPATITIS B CORE ANTIGENS;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
LAMIVUDINE;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
|
EID: 26444521704
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.07.049 Document Type: Article |
Times cited : (26)
|
References (8)
|